Summary:
Radioiodine therapy appears to be an effective means in
controlling thyrotoxicosis and it acts either by destroying
functioning thyroid cells or by inhibiting their ability to
replicate. The variable radiosensitivity of the gland means
that the choice of dose is empirical. Unfortunately all
attempts at dosimetry have thus far failed to reliably
deliver a dose that avoids recurrence and does not
ultimately lead to hypothyroidism. Ninety five patients
(female 66 and male 29) with thyrotoxicosis treated with
radioiodine at the Center for Nuclear Medicine &
Ultrasound, Barisal and their outcome were analyzed
from January 2000 to December 2004. Before radioiodine
administration clinical features of the patients, palpation